Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
Bioorg Med Chem Lett
; 17(14): 3997-4000, 2007 Jul 15.
Article
em En
| MEDLINE
| ID: mdl-17498948
ABSTRACT
A novel series of cyclic benzamidines was synthesized and shown to exhibit NR2B-subtype selective NMDA antagonist activity. Compound 29 is orally active in a carrageenan-induced rat hyperalgesia model of pain.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Benzamidinas
/
Receptores de N-Metil-D-Aspartato
/
Antagonistas de Aminoácidos Excitatórios
Limite:
Animals
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article